Total Funding: 39750000.0
Headquarters: Oxford, Oxfordshire, United Kingdom
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: Less than $1M
Last Funding Type: Series A
Technology: Biopharma, Biotechnology, Health Care, Therapeutics
Last Funding Date: 2022-10-10
Investors Number: 19.0
Founded Date: 2019-09-01
Industry: Early Drug Development